Pancreatic Cancer: Good News and Bad

It appears that a high-school student may have come up with an inexpensive, accurate and early method for detecting pancreatic cancer:

"Jack Andraka [has] developed a simple dip-stick test for levels of mesothelin, a biomarker for early stage pancreatic cancer found in blood and urine ... His novel patent-pending sensor has proved to be 28 times faster, 28 times less expensive, and over 100 times more sensitive than current tests."

This is pretty important stuff: the disease kills over 95% of its victims, usually because it's difficult to detect in its early (more treatable) stages. Being able to catch it early on would be a real boon.

That's the good news.

The bad news, of course, is that The ObamaTax promises to severely limit additional research, let alone development of this new tech:

"As of Jan.1, Obamacare imposes a new tax of 2.3 percent on medical device manufacturers ... The tax is imposed on gross sales -- even if the company does not earn a profit in a given year."

And since we're already seeing med-tech companies rapidly downsizing as a result of that tax, it's no sure thing that young Jack's new invention will ever see the light of day.

Too bad, that.

Share on Google Plus

About Rismal Sido

This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.